Parkinson Disease/ Parkinsonian Disorders

Contributing journals to this collection:
JAMA & Archives Journals

Citations 101-110 of 407 total displayed.

Past content

Clinical Trials
Randomized, Double-blind, Placebo-Controlled Trial on Symptomatic Effects of Coenzyme Q₁₀ in Parkinson Disease

Alexander Storch; Wolfgang H. Jost; Peter Vieregge; Jörg Spiegel; Wolfgang Greulich; Joachim Durner; Thomas Müller; Andreas Kupsch; Henning Henningsen; Wolfgang H. Oertel; Gerd Fuchs; Wilfried Kuhn; Petra Niklowitz; Rainer Koch; Birgit Herting; Heinz Reichmann; for the German Coenzyme Q₁₀ Study Group
Arch Neurol 64.7.nct60005. [Abstract] [Full text] [PDF]  

Original Contributions
Transdermal Rotigotine: Double-blind, Placebo-Controlled Trial in Parkinson Disease

Joseph Jankovic; Ray L. Watts; Wayne Martin; Babak Boroojerdi; for the SP 512 Rotigotine Transdermal System Clinical Study Group
Arch Neurol 2007; 64: 676-682. [Abstract] [Full text] [PDF] [ Notice of Redundant Publication ]  

Health Agencies Update
Creatine for Parkinson

Bridget M. Kuehn
JAMA 2007; 297: 1764-a. [Extract] [Full text] [PDF]  

Original Contributions
Risk Factors for the Development of Pedal Edema in Patients Using Pramipexole

Galit Kleiner-Fisman; David N. Fisman
Arch Neurol 64.6.noc60158. [Abstract] [Full text] [PDF]  

Original Contributions
Mutation of the Linker Region of the Polymerase -1 (POLG1) Gene Associated With Progressive External Ophthalmoplegia and Parkinsonism

Gavin Hudson; Andrew M. Schaefer; Robert W. Taylor; Watcharee Tiangyou; Andrew Gibson; Graham Venables; Philip Griffiths; David J. Burn; Douglass M. Turnbull; Patrick F. Chinnery
Arch Neurol 2007; 64: 553-557. [Abstract] [Full text] [PDF]  

Original Contributions
Smoking, Caffeine, and Nonsteroidal Anti-inflammatory Drugs in Families With Parkinson Disease

Dana B. Hancock; Eden R. Martin; Jeffrey M. Stajich; Rita Jewett; Mark A. Stacy; Burton L. Scott; Jeffery M. Vance; William K. Scott
Arch Neurol 2007; 64: 576-580. [Abstract] [Full text] [PDF]  

Clinical Trials
Effects of Methylphenidate on Response to Oral Levodopa: A Double-blind Clinical Trial

John G. Nutt; Julie H. Carter; Nichole E. Carlson
Arch Neurol 2007; 64: 319-323. [Abstract] [Full text] [PDF]  

Original Contributions
Cardiac Valve Regurgitation With Pergolide Compared With Nonergot Agonists in Parkinson Disease

Richard B. Dewey Jr; Sharon C. Reimold; Padraig E. O’Suilleabhain
Arch Neurol 2007; 64: 377-380. [Abstract] [Full text] [PDF]  

Original Contributions
A Family With Parkinson Disease, Essential Tremor, Bell Palsy, and Parkin Mutations

Hao Deng; Wei-Dong Le; Christine B. Hunter; Nicte Mejia; Wen-Jie Xie; Joseph Jankovic
Arch Neurol 2007; 64: 421-424. [Abstract] [Full text] [PDF]  

Original Contributions
LRRK2 Exon 41 Mutations in Sporadic Parkinson Disease in Europeans

Suzanne Lesage; Sabine Janin; Ebba Lohmann; Anne-Louise Leutenegger; Laurence Leclere; François Viallet; Pierre Pollak; Franck Durif; Stéphane Thobois; Valérie Layet; Marie Vidailhet; Yves Agid; Alexandra Dürr; Alexis Brice; for the French Parkinson's Disease Genetics Study Group
Arch Neurol 2007; 64: 425-430. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41